P21
130,00$
Description
P21 Peptide is a synthetic neuroactive research compound derived from signaling domains of ciliary neurotrophic factor (CNTF). It is classified as a neuroplasticity and synaptogenic peptide, primarily studied for its effects on memory formation, synaptic density, and cognitive resilience. P21 has gained attention in laboratory research for its ability to promote neuronal connectivity without activating classical CNTF receptors, making it a unique tool for studying brain recovery, learning mechanisms, and neurodegenerative pathways.
Epigenetix Labs supplies P21 Peptide 10 mg for laboratory research use only, intended exclusively for qualified professionals conducting in vitro or preclinical studies. This product is strictly for research use only. Not for human or veterinary use.
10 Research-Based Reasons to Study
-
Promotes synaptic plasticity in preclinical models
-
Enhances learning and memory performance
-
Increases dendritic spine density
-
Supports long-term potentiation mechanisms
-
Used in neurodegeneration research frameworks
-
Enables investigation of cognitive resilience pathways
-
Supports hippocampal neuron connectivity studies
-
Valuable tool for brain aging research
-
Facilitates synaptogenesis exploration
-
Common reference compound in neuroplasticity research
Additional information
Additional information
| Weight | 0,006 kg |
|---|---|
| Dimensions | 1,5 × 1,5 × 3,5 cm |
| Scientific Background | P21 is a short synthetic peptide designed to mimic specific intracellular signaling effects associated with CNTF, while avoiding the inflammatory and systemic side effects linked to full CNTF activation. Unlike growth factors or hormonal peptides, P21 acts directly at the level of neuronal signaling and synaptic modulation. Preclinical studies suggest it enhances: synaptogenesis, dendritic spine density, long-term potentiation & neuronal survival signaling. Its mechanism appears to involve downstream activation of pathways associated with learning and memory consolidation, including MAPK/ERK signaling cascades, making P21 especially relevant in cognitive and neurodegeneration research. Importantly, P21 does not function as a hormone, growth factor, or metabolic agent. Its domain is strictly central nervous system research and neuroplasticity biology. |
| Key Research Findings | Preclinical investigations have demonstrated that P21: • Improves learning and memory performance in animal models • Increases synaptic density in hippocampal regions • Enhances long-term potentiation • Supports neuronal connectivity in neurodegenerative frameworks • Shows cognitive protective effects in aging-related brain models Research published in neuroscience and molecular biology literature highlights P21’s role in: • Memory consolidation • Synaptic remodeling • Cognitive recovery models • Alzheimer’s-related experimental frameworks • These findings position P21 as a reference compound for studying brain recovery and synaptic plasticity without endocrine involvement. |
| Purity & Manufacturing Standards | Epigenetix Labs P21 is synthesized by SPPS, purified by HPLC, and validated by MS. Each batch is produced in ISO 9001:2015-certified facilities at ≥98% purity. |
| Research Applications | P21 Peptide is frequently utilized in laboratory research involving: • Brain recovery models • Neuroplasticity studies • Memory formation research • Cognitive decline frameworks • Alzheimer’s disease models • Synaptic density investigations • Neuronal regeneration pathways • Aging-related cognitive impairment • Central nervous system signaling research. |
| Legal Disclaimer | For laboratory research use only. Not for human or veterinary use. Not for therapeutic, diagnostic, or food purposes. Not evaluated by the FDA or regulatory authorities. |








Reviews
There are no reviews yet.